Gene: YPEL2
Official Full Name: yippee like 2provided by HGNC
Gene Summary: Predicted to enable metal ion binding activity. Predicted to be located in nucleolus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12524 | YPEL2 Knockout cell line (HeLa) | Human | YPEL2 | 1:3~1:6 | Negative | Online Inquiry |
KO12525 | YPEL2 Knockout cell line (HCT 116) | Human | YPEL2 | 1:2~1:4 | Negative | Online Inquiry |
KO12526 | YPEL2 Knockout cell line (HEK293) | Human | YPEL2 | 1:3~1:6 | Negative | Online Inquiry |
KO12527 | YPEL2 Knockout cell line (A549) | Human | YPEL2 | 1:3~1:4 | Negative | Online Inquiry |
YPEL2 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the YPEL2 gene, which is implicated in various cellular processes including proliferation, differentiation, and apoptosis. The purpose of these knockout cell lines is to facilitate in-depth research into the functional roles of YPEL2 in biological systems, particularly in understanding its contributions to human diseases such as cancer and neurodegenerative disorders.
The primary mechanism through which YPEL2 Gene Knockout Cell Lines operate involves the use of CRISPR-Cas9 technology to create precise disruptions in the genome. This genetic alteration allows researchers to observe phenotypic changes resulting from the loss of YPEL2 function, providing vital insights into its role in cell cycle regulation and response to stress. By analyzing these phenotypic traits, scientists can develop a better understanding of molecular pathways relevant to various health conditions.
The scientific importance of YPEL2 Gene Knockout Cell Lines cannot be overstated. These models are essential for gene function studies, drug screening, and elucidating mechanisms underlying disease pathogenesis. In clinical settings, they may aid in developing targeted therapies that exploit the vulnerabilities created by the loss of YPEL2, informing next-generation treatments for patients.
Compared to alternative models, such as overexpressing systems or non-specific knockdown approaches, YPEL2 knockout lines offer a cleaner and more effective means of studying gene function without compensatory effects that often confound results. This specificity translates into higher reliability and reproducibility of experimental data.
Researchers and clinicians alike will find YPEL2 Gene Knockout Cell Lines invaluable, as they represent a faithful model for dissecting the biological significance of YPEL2, ultimately guiding therapeutic innovation. Our company prides itself on utilizing cutting-edge gene editing technologies, ensuring that each knockout cell line is validated for scientific integrity and reproducibility, thus empowering the biomedical community with tools necessary for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.